Amundi Purchases 28,476 Shares of agilon health, inc. (NYSE:AGL)

Amundi increased its position in agilon health, inc. (NYSE:AGL) by 2.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 995,295 shares of the company’s stock after buying an additional 28,476 shares during the quarter. Amundi owned 0.24% of agilon health worth $1,891,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also bought and sold shares of the company. Raymond James Financial Inc. purchased a new position in shares of agilon health during the fourth quarter worth approximately $33,000. Symphony Financial Services Inc. raised its position in agilon health by 44.3% in the 4th quarter. Symphony Financial Services Inc. now owns 23,000 shares of the company’s stock worth $44,000 after purchasing an additional 7,058 shares during the period. Charles Schwab Investment Management Inc. lifted its stake in agilon health by 49.2% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 4,541,549 shares of the company’s stock worth $8,629,000 after purchasing an additional 1,498,524 shares during the last quarter. Handelsbanken Fonder AB boosted its position in agilon health by 47.9% during the fourth quarter. Handelsbanken Fonder AB now owns 75,000 shares of the company’s stock valued at $142,000 after buying an additional 24,300 shares during the period. Finally, Ieq Capital LLC bought a new position in shares of agilon health during the fourth quarter valued at about $26,000.

agilon health Stock Performance

agilon health stock opened at $4.19 on Tuesday. agilon health, inc. has a fifty-two week low of $1.50 and a fifty-two week high of $7.73. The stock has a market cap of $1.73 billion, a price-to-earnings ratio of -4.46 and a beta of 0.67. The stock’s 50 day simple moving average is $3.35 and its two-hundred day simple moving average is $2.93. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29.

Analyst Ratings Changes

A number of research firms have recently weighed in on AGL. Needham & Company LLC reissued a “hold” rating on shares of agilon health in a research note on Wednesday, February 26th. Citigroup raised agilon health from a “sell” rating to a “neutral” rating and increased their price objective for the company from $1.75 to $2.25 in a research note on Friday, January 10th. Royal Bank of Canada lifted their target price on shares of agilon health from $3.00 to $3.50 and gave the stock an “outperform” rating in a research note on Wednesday, February 26th. Stifel Nicolaus increased their price target on shares of agilon health from $2.00 to $3.00 and gave the company a “hold” rating in a research report on Wednesday, February 26th. Finally, Macquarie assumed coverage on shares of agilon health in a report on Monday, December 16th. They issued a “neutral” rating and a $3.00 price target on the stock. Two equities research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $3.95.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.